Alloway RR - Search Results

1

Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients.

Schmidt N, Alloway RR, Walsh RC, Sadaka B, Shields AR, Girnita AL, Hanseman DJ, Woodle ES. Schmidt N, et al. Among authors: alloway rr. Transplantation. 2012 Aug 27;94(4):352-61. doi: 10.1097/TP.0b013e318257acf6. Transplantation. 2012. PMID: 22836132

2

The pharmacokinetic profile of standard and low-dose OKT3 induction immunosuppression in renal transplant recipients.

Alloway R, Kotb M, Hathaway D, Ohman M, Strain S, Gaber AO. Alloway R, et al. Transplantation. 1994 Jul 27;58(2):249-53. Transplantation. 1994. PMID: 8042244 Clinical Trial. No abstract available.

3

Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole.

Moore LW, Alloway RR, Acchiardo SR, Vera SR, Shokouh-Amiri M, Gaber AO. Moore LW, et al. Among authors: alloway rr. Transplantation. 1996 Feb 27;61(4):537-41. doi: 10.1097/00007890-199602270-00004. Transplantation. 1996. PMID: 8610377 Clinical Trial.

4

Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.

Alloway RR, Russell WC, Gaber LW, Amiri MH, Vera SR, Gaber AO. Alloway RR, et al. Transplant Proc. 1996 Apr;28(2):995-7. Transplant Proc. 1996. PMID: 8623494 Clinical Trial. No abstract available.

5

Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral.

First MR, Alloway R, Schroeder TJ. First MR, et al. Clin Transplant. 1998 Dec;12(6):518-24. Clin Transplant. 1998. PMID: 9850444

6

Simultaneous kidney-pancreas transplantation without antilymphocyte induction.

Reddy KS, Stratta RJ, Shokouh-Amiri H, Alloway R, Somerville T, Egidi MF, Gaber LW, Gaber AO. Reddy KS, et al. Transplantation. 2000 Jan 15;69(1):49-54. doi: 10.1097/00007890-200001150-00010. Transplantation. 2000. PMID: 10653379

7

The importance of early prevention of renal dysfunction in liver transplant recipients.

Shokouh-Amiri MH, Egidi MF, Lo A, Grewal HP, Vera SR, Stratta RJ, Kizilisik T, Nezakatgoo N, Trofe J, Alloway RR, Cowan PA, Gaber AO. Shokouh-Amiri MH, et al. Among authors: alloway rr. Transplant Proc. 2001 Feb-Mar;33(1-2):1399-400. doi: 10.1016/s0041-1345(00)02526-4. Transplant Proc. 2001. PMID: 11267345 No abstract available.

8

Transmission of donor cancer into cardiothoracic transplant recipients.

Buell JF, Trofe J, Hanaway MJ, Lo A, Rosengard B, Rilo H, Alloway R, Beebe T, First MR, Woodle ES. Buell JF, et al. Surgery. 2001 Oct;130(4):660-6; discussion 666-8. doi: 10.1067/msy.2001.117102. Surgery. 2001. PMID: 11602897

9

Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.

Bruce DS, Sollinger HW, Humar A, Sutherland DE, Light JA, Kaufman DB, Alloway RR, Lo A, Stratta RJ. Bruce DS, et al. Among authors: alloway rr. Transplantation. 2001 Nov 27;72(10):1637-43. doi: 10.1097/00007890-200111270-00010. Transplantation. 2001. PMID: 11726823

10

Strategies to reduce toxicities and improve outcomes in renal transplant recipients.

Lo A, Alloway RR. Lo A, et al. Among authors: alloway rr. Pharmacotherapy. 2002 Mar;22(3):316-28. doi: 10.1592/phco.22.5.316.33198. Pharmacotherapy. 2002. PMID: 11898890 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters